Axa S.A. Akebia Therapeutics, Inc. Transaction History

Axa S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.39 - $13.08 $152,004 - $831,888	-63,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $304,152 - $619,248	45,600 Added 253.33%	63,600 $864,000
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $73,800 - $184,320	18,000 New	18,000 $136,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.